These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 15698711

  • 1. Emerging epidemic of metallo-beta-lactamase-mediated resistances.
    Jones RN, Biedenbach DJ, Sader HS, Fritsche TR, Toleman MA, Walsh TR.
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):77-84. PubMed ID: 15698711
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and in vitro antibacterial properties of 2-(3-bromo-5-isoxazolylideneamino-oxy)acetamido-beta-lactam derivatives.
    Sala A, Chiarino D, Napoletano M, Albini E, Carenzi A.
    Farmaco; 1991 Feb; 46(7-8):887-97. PubMed ID: 1793473
    [Abstract] [Full Text] [Related]

  • 4. The new beta-lactamases.
    Jacoby GA, Munoz-Price LS.
    N Engl J Med; 2005 Jan 27; 352(4):380-91. PubMed ID: 15673804
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM.
    Clin Infect Dis; 2005 Dec 01; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract] [Full Text] [Related]

  • 7. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.
    Chatterjee SS, Karmacharya R, Madhup SK, Gautam V, Das A, Ray P.
    Indian J Med Microbiol; 2010 Dec 01; 28(3):267-8. PubMed ID: 20644325
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).
    Castanheira M, Mendes RE, Woosley LN, Jones RN.
    J Antimicrob Chemother; 2011 Jun 01; 66(6):1409-11. PubMed ID: 21421581
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM, Bonomo RA.
    Curr Opin Microbiol; 2005 Oct 01; 8(5):518-24. PubMed ID: 16126451
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metallo-β-lactamases: a last frontier for β-lactams?
    Cornaglia G, Giamarellou H, Rossolini GM.
    Lancet Infect Dis; 2011 May 01; 11(5):381-93. PubMed ID: 21530894
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.